Talk:Plasmin
This article is rated B-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||
|
Untitled
02:46, 11 November 2015 (UTC)172.78.62.6 (talk)Cite error: There are <ref>
tags on this page without content in them (see the help page).==Plasminogen - Plasmin - Angiostatin ==
The article is called plasmin, but the template is about the gene product, plasminogen, and angiostatin, which is produced from plasmin, is not mentioned.. maybe the article needs some reogranization. --CopperKettle 14:31, 19 September 2009 (UTC)
Receptors
doi:10.1111/jth.12064 is a review about plasminogen receptors and their role in pathology. JFW | T@lk 17:03, 30 January 2013 (UTC)
Interactions
TRANEXAMIC ACID (LYSTEDA) is a new drug approved by the FDA to treat cyclic heavy menstrual bleeding and its mechanism of action is to prevent plasminogen conversion to plasmin. It therefore acts as a antifibrinolytic. Marketing ads tout this as a non-hormonal way to treat cyclic heavy menstrual bleeding but it poses serious risks of blood clots, especially in women using hormonal contraceptives, and for this reason it is contraindicated in that group.
http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022430s004lbl.pdf
- Talk pages with reference errors
- B-Class Physiology articles
- Mid-importance Physiology articles
- Physiology articles about blood
- WikiProject Physiology articles
- B-Class Molecular Biology articles
- Unknown-importance Molecular Biology articles
- B-Class MCB articles
- Low-importance MCB articles
- WikiProject Molecular and Cellular Biology articles
- All WikiProject Molecular Biology articles